Lexicon Pharmaceuticals Inc
Why Achaogen Stock Fell Steeply Yesterday
Yesterday, Achaogen (AKAO) announced that the FDA had approved its antibacterial agent, Zemdri (plazomicin), for adults suffering from complicated urinary tract infections (or cUTI) who don’t have significant treatment options.
Grifols and Myriad Traded above the 100-Day Moving Averages
Grifols (GRFS) only fell by 0.34%. It bucked the trend. There were talks that Moody’s upgraded the ratings from “negative” to “stable.”